CD274 and endometrial cancer: This review aims to provide a comprehensive overview of the current uses of immunotherapy in MMRd endometrial cancer, detailing the pathogenic basis for PD-1 and PD-L1 overexpression, the mechanisms behind the success of immunotherapy, ongoing clinical trials, and future perspectives.